STAT September 28, 2023
Damian Garde and Allison DeAngelis

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, FDA, Govt Agencies, Pharma / Biotech, Trends
Pharma Pulse 12/12/24: Coverage from Trade & Channel Strategies 2024, ASHP Midyear & more
The Impact of the Presidential Election on Pharma: Q&A with Arthur Wong
AbbVie Completes Acquisition of Aliada Therapeutics
The IRA And Post-Approval Clinical Research For Cancer Medicines
Proteomics and AI unite for a new era in medicine and health care

Share This Article